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ntensiﬁcation therapy with levoﬂoxacin and linezolid: a case
eport
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Background: Tuberculosis (TB) remains a worldwide infectious
isease of concern and the spectre of multidrug resistant TB is
ncreasing. Linezolid and levoﬂoxacin are two oral antibiotics with
nown activity against Mycobacterium tuberculosis (MTB). In set-
ings of drug resistant TB, the role of these agents is emerging. We
reated a patient with prolonged viable Acid Fast Bacilli (AFB) with
n intensiﬁed six drug regimen of levoﬂoxacin, linezolid, rifampin,
soniazid, pyrazinamide and ethambutol.
Methods: A 53 year old Black male with diabetes mellitus
nd alcohol abuse presented with six days of fever, night sweats,
yspnea, and cough with yellow sputum. Physical exam showed
emperature of 100.70F, pulse 116, and respiratory rate of 22, with
mbient oxygen saturation 87%. The patient appeared cachectic.
reath sounds were coarse, with some reduction in both upper
ung ﬁelds. Laboratory data indicated anemia and guaiac positive
tools. A subsequent colonoscopy showed near obstructing colon
ancer. Chest radiograph showed left sided lung consolidationwith
pper lobe cavitation. Sputum demonstrated AFB. He was started
n rifampin, isoniazid, pyrazinamide, and ethambutol. After 35
ays, his fever continued. Sputum smear and cultures remained
ositive. Therapy was intensiﬁed with levoﬂoxacin and linezolid.
is nutrition was optimized. The colon cancer was resected. The
TB isolate was reported as pan sensitive.
Results: Finally, after 64 days, 3 consecutive sputum samples
ere negative. His fever resolved. He was discharged on isoniazid
nd rifampin for an extended period of 7 months.
Conclusion: The mean time for sputum conversion after ini-
iation of appropriate therapy in the U.S. varies from 24 to 33
ays. Various factors that delay this include initial cavitary disease,
igh sputum bacillary load, and multidrug resistance TB (MDR-
B). Pending sensitivity data with prolonged viable AFB in sputum
amples, concerns for MDR-TB were raised. We chose a trial of
ix drug intensiﬁed treatment including levoﬂoxacin and linezolid
ith standard antituberculous therapy. We observed no adverse
ffects of treatment after one month with these additional drugs.
e believe the addition of levoﬂoxacin and linzeolid is worthy of
urther study in patients with difﬁcult tuberculous disease.
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Background: Tuberculosis (TB) is a global pandemic and India
is the major TB endemic country. Rapid and accurate diagno-
sis of TB is crucial to facilitate early treatment of infection and
thus to reduce its spread. Spectrum of infection and treatment of
Mycobacterium tuberculosis complex (MTBC) and nontuberculous
mycobacteria (NTM) are entirely different. Newer techniques like
molecular detection techniques are sensitive and enough to detect
and discriminate. These tests are more sophisticated and require
expensive equipment. This study was conducted to evaluate the
usefulness of TB AgMPT64 Kit (SD Bioline) for simple and rapid dis-
crimination between the MTBC and NTM in clinical isolates from
liquid culture, considering GenoType Mycobacterium CM as gold
standard.
Methods: A total of 161 BacT/ALERT MP® positive cultures
(BacT/ALERT 3D TB System bioMérieux, SA) from clinical isolates
during January 2010 to December 2011 were tested with MPT64
kit as per manufacturer’s instructions. Brieﬂy, 100l aliquot of the
positive culture media were placed in to the kit’s well, followed by
15minutes to incubation. Resultswere read as positive forM. tuber-
culosis complex by observing presence of line of precipitation (s).
Further all these isolateswere subjected for identiﬁcation byGeno-
Type Mycobacterium CM (HAINS Lifesciences, GmbH Germany).
Results: Out of 161 culture positive isolates were tested by
MPT64 kit; 111 (68.9%) were positives (MTBC) and 50 (31.1%)
were negative (NTM). We compared MPT64 kit with GenoType
Mycobacterium CM (gold standard) for the detection of MTBC.
The sensitivity, speciﬁcity, positive and negative predictive val-
ues of MPT64 kit for identifying MTBC were 99%, 100%, 98.1%, and
100% respectively. Overall performance of MPT64 kit was excel-
lent, simple, easy, rapid and less time consuming as comparedwith
GenoType Mycobacterium CM.
Conclusion: Rapid TB antigen MPT64 kit is applicable for
positive liquid culture media, and does not require any special
equipment. It can be used for rapid differentiation between MTB-
Cand NTM and helpful in early diagnosis of MTBC and appropriate
management of tuberculosis cases so that spread of TB may be
reduced.
http://dx.doi.org/10.1016/j.ijid.2012.05.972
